-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00272.67% Upside
Atai Life Sciences N.V. Frequently Asked Questions
-
What analysts cover Atai Life Sciences N.V.?
Atai Life Sciences N.V. has been rated by research analysts at Maxim Group in the past 90 days.